We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About bNovate Technologies Stock

Invest in or calculate the value of your shares in bNovate Technologies or other pre-IPO companies through EquityZen's platform.

Get Started

bNovate Technologies Stock (BNNT)

bNovate Technologies develops fully automated analysis instruments.

About bNovate Technologies Stock

Founded

2011

Industries

Manufacturing, Hardware, Software

bNovate Technologies SA was founded in 2011 with the goal to be the best in the field of automated cells analysis. The company is based at the Innovation Park of the Swiss Federal Institute of Technology of Lausanne (EPFL). They started their activities with a few people. Today, bNovate Technologies SA has grown into a strong team of scientific experts and managers who can address the challenge of developing the most demanding, fully automated analysis instruments. They develop instruments for clients, but they also created their own cell detection instruments for drinking water that they distribute through partnering companies.

bNovate Technologies Management

Leadership team at bNovate Technologies

CEO R&D and Operations, Founder and Board Member

Simon Künzi

CEO Sales & Marketing

René Lenggenhager

Locked Features

Join now and verify your accreditation status to gain access to:

  • bNovate Technologies current valuation
  • bNovate Technologies stock price
  • Available deals in bNovate Technologies and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in bNovate Technologies stock?

Accredited investors can buy pre-IPO stock in companies like bNovate Technologies through EquityZen funds. These investments are made available by existing bNovate Technologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell bNovate Technologies stock?

Shareholders can sell their bNovate Technologies stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like bNovate Technologies